Investor patience tested as pharmaceutical stocks take a tumble

The Health Care Select Sector SPDR Fund NYSEARCA: XLV was down 3.81% in the past month and 8.03% in the past three months. The latest round of pharmaceutical stock earnings isn't helping sector performance. S&P 500 components Bristol Myers Squibb Co. NYSE: BMY, AbbVie Inc. NYSE: ABBV, Merck & Co.,…#xlv #bristolmyerssquibbco #bmy #abbvieinc #merckco #johnsonjohnsonnyse #jnj #pfizerinc #pfe #amgeninc
Source: Reuters: Health - Category: Consumer Health News Source Type: news